News
Thermo Fisher Scientifics Advanced Analytical Instruments Recognized Through Respected Industry Awards
Thermo Fisher Scientific, the world leader in serving science, announced that several of its analytical instruments and solutions have received industry recognition through multiple respected awards. These award-wining analytical solutions are enabling scientists and organizations to make the world...
Drug Research
K T Rama Rao Inaugurates BE’s Plant at Genome Valley & Unveils Typhoid Conjugate Vaccine
Mr. K T Rama Rao, Honourable Minister for Information Technology, Industries & Commerce, Municipal Administration and Urban Development, Government of Telangana, inaugurated Biological E. Limitedโs (BE) Plant and unveiled its new Typhoid Conjugate Vaccine (TCV) today in the Special...
News
Thermo Fisher Scientific Launches Next-Generation, Compressor-Free Plate Sealer at SLAS 2020
Thermo Fisher Scientific announces the launch of a next-generation, compressor-free plate sealer, designed to alleviate the maintenance burden on operators, while offering unparalleled process customization capabilities, intuitive operation and significant work efficiencies. Biotechnology, pharmaceutical and academic research laboratories can...
News
CPhI Southeast Asia Report: executives call for track-and-trace schemes in Southeast Asia
CPhIโs ASEAN Pharma 2020 Report points points to Thailand and Indonesia having the largest near-term generics export potential, as regional executives come out in favour of an ASEAN-wide track and trace scheme. The reportโs findings which have been...
News
Inceptua and Portola enter exclusive distribution agreement for Ondexxya
Inceptua, a global pharmaceutical company and service partner and Portola โ US developer and manufacturer of therapeutic agents focusing on thrombosis and other haematological conditions โ have entered into an agreement whereby Inceptua will become Portolaโs exclusive distribution partner...
Drug Research
Regeneron Announces Expanded Collaboration with HHS to Develop Antibody Treatments for New Coronavirus
Regeneronย announced an expanded agreement with the U.S. Department of Health and Human Services (HHS) to develop new treatments combating the novel coronavirus, 2019-nCoV, which was recently declared a global public health emergency by the World Health Organization.
Regeneron has...
Clinical Trials
AIVITA Biomedical completes patient enrollment target in phase 2 GBM trial for glioblastoma
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that it has reached its patient enrollment target in the company's phase 2 clinical trial for glioblastoma. The trial has achieved its enrollment target ahead of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















